Search results
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via AOL· 5 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 5 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 2 days agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 6 days agoProf Peter ...return because a few cancer cells are left in the body, but using a vaccine to target...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 days agoToday, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoResearchers from NYU Langone Health's Perlmutter Cancer Center are presenting their latest findings and research at the 2024 American Society of Clinical Oncology (ASCO) Annual Conference, held ...
